Pediatrix Medical
258 hedge funds and large institutions have $2.18B invested in Pediatrix Medical in 2019 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 86 increasing their positions, 70 reducing their positions, and 30 closing their positions.
137% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 30
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
23% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 70
22% more capital invested
Capital invested by funds: $1.78B → $2.18B (+$399M)
16% more funds holding
Funds holding: 223 → 258 (+35)
0.46% less ownership
Funds ownership: 93.62% → 93.17% (-0.46%)
75% less call options, than puts
Call options by funds: $1.17M | Put options by funds: $4.71M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SV
Starboard Value
New York
|
+$97.3M |
| 2 |
PCP
P2 Capital Partners
New York
|
+$28.8M |
| 3 |
HM
HealthCor Management
New York
|
+$26.9M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$19.8M |
| 5 |
Lazard Asset Management
New York
|
+$17.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$74.2M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
-$52.3M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$39.1M |
| 4 |
Morgan Stanley
New York
|
-$38.5M |
| 5 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
-$32.3M |
MD Hedge Fund Activity: Q4 2019 in Review
258 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2019, worth a combined $2.18B — up 22% from $1.78B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new MD positions and 30 closed out — a net gain of 41 holders — while 86 added to existing stakes and 70 trimmed.
The largest buyer was Starboard Value, opening a new position worth an estimated $97.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $74.2M.
- 258 institutional investors held Pediatrix Medical (MD) as of Q4 2019, up from 223 in Q3 2019.
- Funds reported $2.18B of Pediatrix Medical stock for Q4 2019, up 22% quarter-over-quarter.
- 71 funds opened new Pediatrix Medical positions in Q4 2019 and 30 closed out, a net change of +41 holders.
- The largest Pediatrix Medical buyer in Q4 2019 was Starboard Value, an estimated $97.3M added.
- The largest Pediatrix Medical seller in Q4 2019 was T. Rowe Price Associates, an estimated $74.2M sold.
Based on aggregated 13F filings for Q4 2019.